| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadherin binding | 5.59e-05 | 339 | 101 | 9 | GO:0045296 | |
| GeneOntologyMolecularFunction | Gq/11-coupled serotonin receptor activity | 7.57e-05 | 3 | 101 | 2 | GO:0001587 | |
| GeneOntologyCellularComponent | G protein-coupled serotonin receptor complex | 1.38e-04 | 4 | 101 | 2 | GO:0098666 | |
| Domain | ARM-like | 1.93e-07 | 270 | 99 | 11 | IPR011989 | |
| Domain | ARM-type_fold | SAAL1 ATR APC XPO1 TEX10 TRRAP RYR3 JUP CTNNBL1 PKP1 ULK4 PPP6R3 | 2.37e-07 | 339 | 99 | 12 | IPR016024 |
| Domain | - | 2.85e-07 | 222 | 99 | 10 | 1.25.10.10 | |
| Domain | Aquaporin_12 | 2.78e-05 | 2 | 99 | 2 | IPR023265 | |
| Domain | Aquaporin_11/12 | 8.32e-05 | 3 | 99 | 2 | IPR016697 | |
| Domain | HEAT | 2.53e-04 | 58 | 99 | 4 | IPR000357 | |
| Domain | CH | 3.92e-04 | 65 | 99 | 4 | SM00033 | |
| Domain | FAT | 4.11e-04 | 6 | 99 | 2 | PS51189 | |
| Domain | FATC | 4.11e-04 | 6 | 99 | 2 | PS51190 | |
| Domain | FAT | 4.11e-04 | 6 | 99 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 4.11e-04 | 6 | 99 | 2 | IPR003151 | |
| Domain | FATC_dom | 4.11e-04 | 6 | 99 | 2 | IPR003152 | |
| Domain | PIK_FAT | 4.11e-04 | 6 | 99 | 2 | IPR014009 | |
| Domain | FATC | 4.11e-04 | 6 | 99 | 2 | SM01343 | |
| Domain | CH | 5.21e-04 | 70 | 99 | 4 | PF00307 | |
| Domain | HEAT_REPEAT | 5.21e-04 | 70 | 99 | 4 | PS50077 | |
| Domain | - | 5.50e-04 | 71 | 99 | 4 | 1.10.418.10 | |
| Domain | Arm | 5.83e-04 | 31 | 99 | 3 | PF00514 | |
| Domain | CH | 6.11e-04 | 73 | 99 | 4 | PS50021 | |
| Domain | Spectrin/alpha-actinin | 6.41e-04 | 32 | 99 | 3 | IPR018159 | |
| Domain | SPEC | 6.41e-04 | 32 | 99 | 3 | SM00150 | |
| Domain | CH-domain | 6.77e-04 | 75 | 99 | 4 | IPR001715 | |
| Domain | Znf_SWIM | 9.77e-04 | 9 | 99 | 2 | IPR007527 | |
| Domain | ZF_SWIM | 9.77e-04 | 9 | 99 | 2 | PS50966 | |
| Domain | 5HT_rcpt | 9.77e-04 | 9 | 99 | 2 | IPR002231 | |
| Domain | ARM_REPEAT | 1.24e-03 | 40 | 99 | 3 | PS50176 | |
| Domain | ARM | 1.24e-03 | 40 | 99 | 3 | SM00185 | |
| Domain | Armadillo | 1.98e-03 | 47 | 99 | 3 | IPR000225 | |
| Domain | HEAT | 2.10e-03 | 48 | 99 | 3 | PF02985 | |
| Domain | Kinase-like_dom | 2.34e-03 | 542 | 99 | 9 | IPR011009 | |
| Domain | MIP | 2.43e-03 | 14 | 99 | 2 | PS00221 | |
| Domain | MIP | 2.43e-03 | 14 | 99 | 2 | PF00230 | |
| Domain | MIP | 2.79e-03 | 15 | 99 | 2 | IPR000425 | |
| Domain | - | 2.79e-03 | 15 | 99 | 2 | 1.20.1080.10 | |
| Domain | Aquaporin-like | 2.79e-03 | 15 | 99 | 2 | IPR023271 | |
| Domain | - | 3.18e-03 | 16 | 99 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.18e-03 | 16 | 99 | 2 | SM00146 | |
| Domain | HEAT_type_2 | 3.59e-03 | 17 | 99 | 2 | IPR021133 | |
| Domain | PI3/4_kinase_cat_dom | 4.03e-03 | 18 | 99 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 4.03e-03 | 18 | 99 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 4.03e-03 | 18 | 99 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 4.03e-03 | 18 | 99 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.03e-03 | 18 | 99 | 2 | PS00916 | |
| Pubmed | FAM193B GAPVD1 RAPGEF6 KIAA0586 APC SPAG5 CEP350 MACF1 GOLGA3 PPP6R3 | 7.18e-10 | 209 | 103 | 10 | 36779422 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GAPVD1 RAPGEF6 HIVEP1 UBAP2 MYCBP2 RIPK2 APC DZIP1 PABIR2 MAP3K3 CEP350 JUP PLEKHA3 MACF1 PPIP5K2 ABTB2 | 5.23e-09 | 861 | 103 | 16 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UNC13B FAM193B RAPGEF6 MYCBP2 TMEM94 SHC1 TEP1 TRRAP FAAP100 FASN ZNF335 EHMT1 ULK4 ABTB2 HR | 9.26e-07 | 1105 | 103 | 15 | 35748872 |
| Pubmed | 1.92e-06 | 486 | 103 | 10 | 20936779 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GAPVD1 HTR2B HSPH1 RIPK2 XPO1 TEX10 TRRAP RYR3 EIF2AK4 ZNF292 | 2.34e-06 | 497 | 103 | 10 | 36774506 |
| Pubmed | 3.59e-06 | 407 | 103 | 9 | 12693553 | ||
| Pubmed | 3.87e-06 | 216 | 103 | 7 | 31519766 | ||
| Pubmed | 4.45e-06 | 418 | 103 | 9 | 34709266 | ||
| Pubmed | AKAP6 UNC13B MYCBP2 SYNE1 HSPH1 APC ZBTB47 DZIP1 RYR3 CEP350 ZNF451 NAV3 MACF1 GOLGA3 ZNF292 | 5.84e-06 | 1285 | 103 | 15 | 35914814 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24244317 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16517693 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 1779432 | ||
| Pubmed | Expression and function of serotonin 2A and 2B receptors in the mammalian respiratory network. | 8.69e-06 | 2 | 103 | 2 | 21789169 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 36167651 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 35742953 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22135723 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 31903123 | ||
| Pubmed | 5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes. | 8.69e-06 | 2 | 103 | 2 | 23346101 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 33204717 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15862800 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 31787571 | ||
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 8.69e-06 | 2 | 103 | 2 | 15809071 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22127701 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19726746 | ||
| Pubmed | Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor. | 8.69e-06 | 2 | 103 | 2 | 27048591 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | UNC13B SAAL1 HIVEP1 UBAP2 MYCBP2 APC TEX10 TRRAP PABIR2 JUP PKP1 EIF2AK4 PPP6R3 | 8.79e-06 | 1005 | 103 | 13 | 19615732 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.17e-05 | 256 | 103 | 7 | 33397691 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | GAPVD1 ATR TMEM94 HSPH1 RIPK2 SHC1 TEX10 TRRAP MAP3K3 MET EIF2AK4 PPP6R3 | 1.65e-05 | 910 | 103 | 12 | 36736316 |
| Pubmed | 1.74e-05 | 496 | 103 | 9 | 31343991 | ||
| Pubmed | Heterodimers of serotonin receptor subtypes 2 are driven by 5-HT2C protomers. | 2.60e-05 | 3 | 103 | 2 | 28258217 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 38732103 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 18703043 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 15831837 | ||
| Pubmed | The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. | 2.60e-05 | 3 | 103 | 2 | 7731718 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 26857837 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 7582481 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 24089568 | ||
| Pubmed | Three-dimensional structure of the armadillo repeat region of beta-catenin. | 2.60e-05 | 3 | 103 | 2 | 9298899 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 12070164 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 24708867 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 19057895 | ||
| Pubmed | Serotonin and the 5-HT(2B) receptor in the development of enteric neurons. | 2.60e-05 | 3 | 103 | 2 | 10627607 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 33036707 | ||
| Pubmed | Expression of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors in the mouse embryo. | 2.60e-05 | 3 | 103 | 2 | 10978843 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 29145495 | ||
| Pubmed | Plakoglobin is required for effective intermediate filament anchorage to desmosomes. | 2.60e-05 | 3 | 103 | 2 | 18496566 | |
| Pubmed | Serotonin signals through a gut-liver axis to regulate hepatic steatosis. | 2.60e-05 | 3 | 103 | 2 | 30446669 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 11707392 | ||
| Pubmed | Neuroendocrine signaling via the serotonin transporter regulates clearance of apoptotic cells. | 2.60e-05 | 3 | 103 | 2 | 24570000 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 21207416 | ||
| Pubmed | Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin receptor genes. | 2.60e-05 | 3 | 103 | 2 | 1381232 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 2.62e-05 | 195 | 103 | 6 | 17110338 | |
| Pubmed | 2.77e-05 | 20 | 103 | 3 | 21689717 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | GAPVD1 SAAL1 SYNE1 APC XPO1 FAAP100 SPAG5 CEP350 DHX15 FASN ZNF451 CTNNBL1 EHMT1 | 3.76e-05 | 1155 | 103 | 13 | 20360068 |
| Pubmed | 3.76e-05 | 421 | 103 | 8 | 36976175 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.13e-05 | 440 | 103 | 8 | 34244565 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 11136974 | ||
| Pubmed | Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. | 5.19e-05 | 4 | 103 | 2 | 25036629 | |
| Pubmed | Modulation of serotonergic receptor signaling and cross-talk by prion protein. | 5.19e-05 | 4 | 103 | 2 | 15590675 | |
| Pubmed | EGF-receptor specificity for phosphotyrosine-primed substrates provides signal integration with Src. | 5.19e-05 | 4 | 103 | 2 | 26551075 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 11150294 | ||
| Pubmed | High-fructose corn syrup enhances intestinal tumor growth in mice. | 5.19e-05 | 4 | 103 | 2 | 30898933 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 18938767 | ||
| Pubmed | Post-translational modifications regulate distinct functions of CARMA1 and BCL10. | 5.19e-05 | 4 | 103 | 2 | 17468049 | |
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 8074697 | ||
| Pubmed | 5.19e-05 | 4 | 103 | 2 | 11348595 | ||
| Pubmed | Signaling by HGF and KGF in corneal epithelial cells: Ras/MAP kinase and Jak-STAT pathways. | 5.19e-05 | 4 | 103 | 2 | 9660480 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GAPVD1 MYCBP2 SYNE1 XPO1 TEX10 TRRAP CEP350 DHX15 JUP FASN PKP1 MACF1 | 5.20e-05 | 1024 | 103 | 12 | 24711643 |
| Pubmed | 5.81e-05 | 225 | 103 | 6 | 12168954 | ||
| Pubmed | FAM193B MYCBP2 ZSWIM5 TMEM94 KIAA0586 FAAP100 PABIR2 MAP3K3 TCAIM ZNF451 EIF2AK4 CFAP46 PPP6R3 | 6.30e-05 | 1215 | 103 | 13 | 15146197 | |
| Pubmed | 6.49e-05 | 335 | 103 | 7 | 15741177 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 7.01e-05 | 27 | 103 | 3 | 18649358 | |
| Pubmed | 7.90e-05 | 76 | 103 | 4 | 27542412 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GAPVD1 HIVEP1 ATR SYNE1 HSPH1 KIAA0586 XPO1 GSR DHX15 JUP FASN CTNNBL1 EHMT1 PKP1 | 8.04e-05 | 1425 | 103 | 14 | 30948266 |
| Pubmed | 8.31e-05 | 77 | 103 | 4 | 19505873 | ||
| Pubmed | Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. | 8.64e-05 | 5 | 103 | 2 | 17113391 | |
| Pubmed | Defining the interactions between intermediate filaments and desmosomes. | 8.64e-05 | 5 | 103 | 2 | 9606214 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 7890674 | ||
| Pubmed | Expression and interaction of different catenins in colorectal carcinoma cells. | 8.64e-05 | 5 | 103 | 2 | 11712088 | |
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 28716720 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 10749680 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 9165122 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 7651399 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 8833759 | ||
| Pubmed | 8.64e-05 | 5 | 103 | 2 | 19136012 | ||
| Pubmed | Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein. | 8.64e-05 | 5 | 103 | 2 | 8662733 | |
| Pubmed | 8.72e-05 | 29 | 103 | 3 | 18239623 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYCBP2 SYNE1 APC XPO1 TEX10 TRRAP DHX15 CTNNBL1 EHMT1 MACF1 PPIP5K2 ZNF292 | 8.78e-05 | 1082 | 103 | 12 | 38697112 |
| Pubmed | 8.97e-05 | 151 | 103 | 5 | 17043677 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 9.65e-05 | 357 | 103 | 7 | 37059091 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GAPVD1 RAPGEF6 HIVEP1 ATR MYCBP2 XPO1 TRRAP FASN ZNF335 PPP6R3 | 1.03e-04 | 774 | 103 | 10 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FAM193B GAPVD1 RAPGEF6 UBAP2 HSPH1 SPAG5 GSR JUP FASN MACF1 PPP6R3 | 1.04e-04 | 934 | 103 | 11 | 33916271 |
| Pubmed | 1.13e-04 | 493 | 103 | 8 | 15368895 | ||
| Pubmed | 1.14e-04 | 494 | 103 | 8 | 26831064 | ||
| Pubmed | 1.16e-04 | 255 | 103 | 6 | 15324660 | ||
| Pubmed | MYCBP2 HSPH1 APC XPO1 TRRAP GSR DHX15 MET JUP FASN EHMT1 MACF1 PPP6R3 | 1.21e-04 | 1297 | 103 | 13 | 33545068 | |
| Pubmed | 1.29e-04 | 33 | 103 | 3 | 23718855 | ||
| Pubmed | 1.29e-04 | 6 | 103 | 2 | 25559195 | ||
| Pubmed | 1.29e-04 | 6 | 103 | 2 | 26173098 | ||
| Pubmed | Genetic predictors of depressive symptoms in cardiac patients. | 1.29e-04 | 6 | 103 | 2 | 18618671 | |
| Interaction | YWHAG interactions | GAPVD1 RAPGEF6 HIVEP1 UBAP2 MYCBP2 HSPH1 RIPK2 SHC1 APC DZIP1 XPO1 TRRAP PABIR2 TESPA1 MAP3K3 LRCH3 CEP350 DHX15 JUP PLEKHA3 MACF1 PPIP5K2 PPP6R3 | 2.22e-08 | 1248 | 98 | 23 | int:YWHAG |
| Interaction | KDM1A interactions | GAPVD1 RAPGEF6 HIVEP1 MYCBP2 SHC1 APC XPO1 TRRAP SPAG5 CEP350 CRYAA DHX15 JUP FASN ZNF451 ZNF641 EHMT1 GOLGA3 PPP6R3 | 1.14e-07 | 941 | 98 | 19 | int:KDM1A |
| Interaction | YWHAH interactions | CDC42BPG GAPVD1 RAPGEF6 HIVEP1 UBAP2 MYCBP2 HSPH1 RIPK2 APC DZIP1 XPO1 PABIR2 TESPA1 MAP3K3 CEP350 JUP PLEKHA3 MACF1 PPIP5K2 | 1.26e-06 | 1102 | 98 | 19 | int:YWHAH |
| Interaction | YWHAB interactions | GAPVD1 RAPGEF6 HIVEP1 MYCBP2 HSPH1 RIPK2 APC DZIP1 TRRAP PABIR2 TESPA1 MAP3K3 CEP350 DHX15 MACF1 PPIP5K2 VCAM1 | 7.20e-06 | 1014 | 98 | 17 | int:YWHAB |
| Interaction | DTNBP1 interactions | 1.43e-05 | 162 | 98 | 7 | int:DTNBP1 | |
| Interaction | GSK3A interactions | FAM193B GAPVD1 RAPGEF6 KIAA0586 APC SPAG5 CEP350 DHX15 MACF1 GOLGA3 PPP6R3 | 1.58e-05 | 464 | 98 | 11 | int:GSK3A |
| Interaction | VSIG2 interactions | 1.70e-05 | 32 | 98 | 4 | int:VSIG2 | |
| Interaction | GSK3B interactions | FAM193B GAPVD1 RAPGEF6 HSPH1 KIAA0586 APC XPO1 SPAG5 CEP350 MET FASN MACF1 TSKS GOLGA3 PPP6R3 | 1.87e-05 | 868 | 98 | 15 | int:GSK3B |
| Interaction | YWHAE interactions | GAPVD1 RAPGEF6 HIVEP1 MYCBP2 RIPK2 SHC1 APC ZC3HC1 XPO1 PABIR2 TESPA1 MAP3K3 LRCH3 JUP PLEKHA3 MACF1 GOLGA3 VCAM1 | 3.13e-05 | 1256 | 98 | 18 | int:YWHAE |
| Interaction | ZYX interactions | 3.25e-05 | 329 | 98 | 9 | int:ZYX | |
| Interaction | YWHAZ interactions | CDC42BPG GAPVD1 RAPGEF6 HIVEP1 MYCBP2 APC DZIP1 XPO1 PABIR2 TESPA1 MAP3K3 SPAG5 JUP PLEKHA3 MACF1 PPIP5K2 GOLGA3 VCAM1 | 5.92e-05 | 1319 | 98 | 18 | int:YWHAZ |
| Interaction | HDAC1 interactions | GAPVD1 RAPGEF6 HIVEP1 ATR MYCBP2 HSPH1 APC XPO1 SPAG5 LRCH3 JUP FASN EHMT1 GOLGA3 PPP6R3 HR | 8.37e-05 | 1108 | 98 | 16 | int:HDAC1 |
| Interaction | BRCA1 interactions | MMS22L GAPVD1 HIVEP1 UBAP2 ATR HSPH1 ZBTB47 XPO1 FAAP100 MAP3K3 SPAG5 CEP350 DHX15 GPR161 JUP FASN PPP6R3 | 1.01e-04 | 1249 | 98 | 17 | int:BRCA1 |
| Cytoband | 1p32-p31 | 1.78e-04 | 9 | 103 | 2 | 1p32-p31 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 4.10e-04 | 9 | 62 | 2 | 90 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.30e-04 | 43 | 62 | 3 | 409 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 8.81e-04 | 13 | 62 | 2 | 170 | |
| GeneFamily | Aquaporins | 1.03e-03 | 14 | 62 | 2 | 305 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GAPVD1 HIVEP1 ATR MYCBP2 APC XPO1 TRRAP CEP350 DHX15 TGFB2 ZNF451 NAV3 MACF1 BICRAL PPIP5K2 ZNF292 | 2.00e-07 | 856 | 102 | 16 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | GAPVD1 HIVEP1 ATR MYCBP2 XPO1 TRRAP CEP350 DHX15 TGFB2 ZNF292 | 1.42e-05 | 466 | 102 | 10 | M13522 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | RAPGEF6 HIVEP1 MYCBP2 HSPH1 KIAA0586 APC XPO1 SPAG5 FASN MACF1 EIF2AK4 ZNF292 | 1.24e-05 | 564 | 99 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | RAPGEF6 RUNDC3B HSPH1 DZIP1 TESPA1 CEP350 MACF1 SARAF ZNF292 | 2.77e-05 | 336 | 99 | 9 | GSM538413_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MMS22L SAAL1 ATR ZSWIM5 HSPH1 KIAA0586 APC XPO1 TEX10 SPAG5 LRCH3 CEP350 FASN PRELID3A PKP1 MACF1 ZNF292 | 6.59e-05 | 1257 | 99 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | UNC13B SAAL1 THSD7A OSTM1 ZSWIM5 HSPH1 KIAA0586 APC SPAG5 LRCH3 FASN CFAP54 PRELID3A MACF1 ZNF292 | 1.13e-04 | 1060 | 99 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | MMS22L SAAL1 ATR ZSWIM5 HSPH1 KIAA0586 APC XPO1 TEX10 SPAG5 LRCH3 CEP350 FASN PRELID3A PKP1 MACF1 VCAM1 ZNF292 | 1.27e-04 | 1459 | 99 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.61e-07 | 186 | 103 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.02e-07 | 190 | 103 | 7 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.13e-07 | 191 | 103 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-06 | 170 | 103 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 4.58e-06 | 185 | 103 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-06 | 197 | 103 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.95e-06 | 199 | 103 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.15e-06 | 200 | 103 | 6 | cf1991853e10c562edae9a0d71a209f35b07db80 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.15e-06 | 200 | 103 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.15e-06 | 200 | 103 | 6 | 7618ae284625c5c121bcc00eb9f07e5b1e3adf23 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.15e-06 | 200 | 103 | 6 | 23b319bf7e5ae03e5baa777c951da9bfc97cca8c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-05 | 136 | 103 | 5 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.62e-05 | 136 | 103 | 5 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-05 | 159 | 103 | 5 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.09e-05 | 165 | 103 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.09e-05 | 165 | 103 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 4.98e-05 | 172 | 103 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-05 | 173 | 103 | 5 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.02e-05 | 179 | 103 | 5 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 6.34e-05 | 181 | 103 | 5 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-05 | 181 | 103 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-05 | 181 | 103 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 6.34e-05 | 181 | 103 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 6.68e-05 | 183 | 103 | 5 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 6.86e-05 | 184 | 103 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 184 | 103 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.04e-05 | 185 | 103 | 5 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 7.22e-05 | 186 | 103 | 5 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.22e-05 | 186 | 103 | 5 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.59e-05 | 188 | 103 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 188 | 103 | 5 | 61422c7919ca0ea02d6be4302f11b169a3ce35e5 | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.59e-05 | 188 | 103 | 5 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 188 | 103 | 5 | 18698f0b22ccbc2b93759acc1c8dbdb30a6b5a16 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 7.78e-05 | 189 | 103 | 5 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.78e-05 | 189 | 103 | 5 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.98e-05 | 190 | 103 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 7.98e-05 | 190 | 103 | 5 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 7.98e-05 | 190 | 103 | 5 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.18e-05 | 191 | 103 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 8.18e-05 | 191 | 103 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 8.38e-05 | 192 | 103 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-05 | 192 | 103 | 5 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 8.38e-05 | 192 | 103 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 193 | 103 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 193 | 103 | 5 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 8.59e-05 | 193 | 103 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.59e-05 | 193 | 103 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.59e-05 | 193 | 103 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.59e-05 | 193 | 103 | 5 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 193 | 103 | 5 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.80e-05 | 194 | 103 | 5 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.80e-05 | 194 | 103 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.80e-05 | 194 | 103 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.01e-05 | 195 | 103 | 5 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.46e-05 | 197 | 103 | 5 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.46e-05 | 197 | 103 | 5 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.46e-05 | 197 | 103 | 5 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.92e-05 | 199 | 103 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.92e-05 | 199 | 103 | 5 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.92e-05 | 199 | 103 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Transitional_AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.92e-05 | 199 | 103 | 5 | e04a57a55c724091db353e2b3baf84372d788728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 200 | 103 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 200 | 103 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-04 | 200 | 103 | 5 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.02e-04 | 200 | 103 | 5 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Parenchymal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | 4e5b6cb014d9bcb58e13c7511c86c43e27c496e4 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 200 | 103 | 5 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 200 | 103 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.91e-04 | 123 | 103 | 4 | 12b87d06e62f142e18424aae5c87454e78e713f0 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.35e-04 | 49 | 58 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.87e-06 | 198 | 101 | 8 | 3738_DN | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.10e-06 | 200 | 101 | 8 | 4525_DN | |
| Drug | seganserin | 9.94e-06 | 10 | 101 | 3 | CID000071767 | |
| Disease | Intellectual Disability | 3.24e-06 | 447 | 101 | 10 | C3714756 | |
| Disease | Benign neoplasm of stomach | 2.56e-05 | 17 | 101 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.56e-05 | 17 | 101 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.56e-05 | 17 | 101 | 3 | C0154060 | |
| Disease | anorexia nervosa (is_implicated_in) | 3.47e-05 | 3 | 101 | 2 | DOID:8689 (is_implicated_in) | |
| Disease | Stomach Carcinoma | 4.95e-05 | 21 | 101 | 3 | C0699791 | |
| Disease | breast cancer (implicated_via_orthology) | 8.48e-05 | 25 | 101 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | Insulinogenic index measurement | 1.15e-04 | 5 | 101 | 2 | EFO_0009961 | |
| Disease | sexual dimorphism measurement | GAPVD1 RAPGEF6 APC MAP3K3 TGFB2 CMIP ZNF335 ULK4 MACF1 CARD11 RMC1 PPP6R3 | 4.01e-04 | 1106 | 101 | 12 | EFO_0021796 |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.04e-04 | 181 | 101 | 5 | DOID:684 (is_implicated_in) | |
| Disease | HEPATOCELLULAR CARCINOMA | 4.11e-04 | 9 | 101 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 4.11e-04 | 9 | 101 | 2 | cv:C2239176 | |
| Disease | Congenital Heart Defects | 4.66e-04 | 44 | 101 | 3 | C0018798 | |
| Disease | medulloblastoma (is_implicated_in) | 5.13e-04 | 10 | 101 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | comparative body size at age 10, self-reported | 6.14e-04 | 420 | 101 | 7 | EFO_0009819 | |
| Disease | colon cancer (implicated_via_orthology) | 6.25e-04 | 11 | 101 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 8.08e-04 | 121 | 101 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Malignant Neoplasms | 9.97e-04 | 128 | 101 | 4 | C0006826 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 9.97e-04 | 128 | 101 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 9.97e-04 | 128 | 101 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 9.97e-04 | 128 | 101 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 9.97e-04 | 128 | 101 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 9.97e-04 | 128 | 101 | 4 | C0007134 | |
| Disease | ovarian neoplasm | 1.18e-03 | 134 | 101 | 4 | C0919267 | |
| Disease | body weight | AKAP6 UNC13B MMS22L GAPVD1 HIVEP1 RIPK2 ZSWIM6 TEX10 TGFB2 FASN ULK4 RMC1 | 1.26e-03 | 1261 | 101 | 12 | EFO_0004338 |
| Disease | Malignant neoplasm of ovary | 1.28e-03 | 137 | 101 | 4 | C1140680 | |
| Disease | visceral adipose tissue measurement | 1.35e-03 | 481 | 101 | 7 | EFO_0004765 | |
| Disease | body fat percentage | 1.47e-03 | 488 | 101 | 7 | EFO_0007800 | |
| Disease | Eye Abnormalities | 1.53e-03 | 17 | 101 | 2 | C0015393 | |
| Disease | parental longevity | 1.57e-03 | 494 | 101 | 7 | EFO_0007796 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.60e-03 | 364 | 101 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.70e-03 | 148 | 101 | 4 | C0279702 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.73e-03 | 69 | 101 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.88e-03 | 152 | 101 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 1.91e-03 | 19 | 101 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Autistic Disorder | 2.07e-03 | 261 | 101 | 5 | C0004352 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.15e-03 | 670 | 101 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | taste liking measurement | 2.21e-03 | 388 | 101 | 6 | EFO_0010155 | |
| Disease | periodontitis (biomarker_via_orthology) | 2.33e-03 | 21 | 101 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 2.86e-03 | 702 | 101 | 8 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILESASTNQTSMYLC | 96 | A0A5B6 | |
| SMNSSEEICLLTTFA | 766 | Q9HCE0 | |
| TLVLCDSCNQTTLQM | 346 | P41595 | |
| STIEATSNCTDLLKM | 1836 | Q96N23 | |
| TANLSLQDRKSCSMS | 816 | Q9NP73 | |
| SDLHLLQSLMAQSCS | 126 | Q8IXF9 | |
| ENLFDSLCSCLMLSS | 311 | Q8WYA6 | |
| LNMEESVTISSCDLL | 1386 | Q9P2K8 | |
| RDLTLRDSCTDNSMQ | 66 | Q6ZN30 | |
| ACTVQNESISELTMS | 1006 | Q4VNC1 | |
| CLSNMTLLESSLQEL | 211 | Q86UK0 | |
| LSHLMQNTCLSSNDI | 101 | Q8N2C3 | |
| VLRSFDSMISTNCTE | 266 | P00390 | |
| MDILCEENTSLSSTT | 1 | P28223 | |
| SLCSLNMNSTKLSAD | 736 | Q8IY22 | |
| ALSQSCSASETMRDV | 2086 | Q8IYW2 | |
| NINTCREMISLLDSN | 576 | A6NHC0 | |
| SDLHLLQSLMAQSCS | 126 | A6NM10 | |
| YNCSNEVLSITAMLS | 581 | O43143 | |
| SCLRLNTNGMVDSSV | 216 | Q6DT37 | |
| TDDSALCMSLSGLNQ | 541 | Q96II8 | |
| MENCSAASTFLTDSL | 1 | Q6ZRQ5 | |
| CSTIMNLLSLANEDS | 1401 | Q14C86 | |
| LMSSNSTDLPLNIEC | 276 | Q92598 | |
| ACSLMLTQFVSSQAL | 656 | O43593 | |
| GEQASMSCRSSQSLL | 36 | A0A0A0MRZ7 | |
| ETESSMLSCQLALKS | 46 | Q8IVL0 | |
| NSLTSMGNVVTCELS | 696 | O94854 | |
| SDNSSTAMLTDCIQQ | 496 | P57789 | |
| TSESQSCARSLLMAD | 136 | Q86WC4 | |
| DVLMATCVLENSSSF | 521 | Q0VG06 | |
| LSLPMQETQLCSTDS | 126 | Q08378 | |
| RTMQNTSDLDTARCT | 191 | P14923 | |
| QLCLDPMTNDSSTLD | 541 | Q8TCU5 | |
| MLSPDAAQLSDLSSC | 186 | Q7Z309 | |
| SGSLMTLSNVSCLSN | 46 | Q9UHC9 | |
| SDLCQLSTQTVFSML | 1571 | Q13535 | |
| SSILADSHLEMTCNN | 956 | Q6AI39 | |
| TTQVLSLSSLCDMAN | 211 | Q6ZMU1 | |
| IRASFSVCELSMDSN | 566 | Q96PV7 | |
| ECNALFQTMSSVTNL | 146 | Q7Z4T8 | |
| LCKRQTDSSSSDMQA | 951 | Q5VT06 | |
| ATMCSAQDRTDLLNV | 16 | P14207 | |
| MSLNSSLSCRKELSN | 1 | Q8N6U8 | |
| LCGEQMTTSTSNQTL | 821 | A0A0U1RQI7 | |
| QSALSCSLSADGMLT | 126 | P02489 | |
| MTANSVSVATCEQLT | 441 | Q6SJ93 | |
| ALDTACSSSLMALQN | 156 | P49327 | |
| SICFIMSSSTNVDLL | 186 | Q96ER3 | |
| EITTLANNQCMATES | 531 | Q9H9B1 | |
| NLNISSQLDACTMSL | 781 | Q9BXL7 | |
| SNSNDCMRDSSQILT | 51 | Q5TDP6 | |
| QCMLDPLSSAENSLS | 211 | Q99759 | |
| METTSLLLCIGNNSS | 271 | Q3ZCT8 | |
| SSSMLNNIINLCRSS | 681 | Q13835 | |
| GNESCTLTLSESTMN | 606 | P08581 | |
| ICSIENMENVSSSRA | 126 | Q96NL0 | |
| SSILEEGSSVNMTCL | 521 | P19320 | |
| CSLSVEHIQSLNTNM | 131 | Q8N3R3 | |
| VSNCSVDSMSAALQD | 1276 | Q8TEU7 | |
| MTTELQSLCSLLQES | 976 | Q96R06 | |
| TEVMSSNSTLEQCTL | 1541 | Q9UPZ6 | |
| MDLCQALESLSSAIT | 1596 | Q8NF91 | |
| QSCLENLVSQMALSE | 2941 | Q8NF91 | |
| SSADSCNMSGLITIV | 166 | Q96BY9 | |
| MELCSTNITLTNLVS | 91 | Q96N28 | |
| SCMAQRTDAVLNIST | 266 | Q9UHJ6 | |
| MNDSTGQSLTALSCA | 266 | O75592 | |
| LLSSDQCSVSQMDTL | 611 | Q86YF9 | |
| ILCSQTLSMESAVNT | 941 | Q8N961 | |
| DTETTTNSEMCLLNA | 1371 | Q13023 | |
| SRTLLAMSSSQDSCI | 331 | P25054 | |
| TVALSLSTCSTLDMD | 16 | P61812 | |
| SLESMQLSLITCSQC | 261 | Q86WB0 | |
| SLCSATAQNLTDMNT | 756 | Q9Y4E5 | |
| ASRTSESLCQNNMVI | 156 | O14980 | |
| ASLSSSMNTANSLCL | 756 | Q5T6F2 | |
| ESQQCELASTMLTAA | 801 | Q9P217 | |
| QCSQRMLSFSDALLS | 31 | Q9BSA9 | |
| LLCSTLVSEVNMNNT | 251 | Q99973 | |
| LSVCSQMLSESDRAS | 391 | Q96DM3 | |
| DSSRDRNLTNCSSVM | 1196 | Q12767 | |
| QSLSGLMQSCSVLDL | 3681 | Q15413 | |
| MTEACLNQSLDALLS | 451 | O43353 | |
| MALNSCTTSINSDLQ | 1731 | O60281 | |
| MVSLANASTLQKDCS | 441 | Q9NXF1 | |
| LLLQGSSRDSCNDSM | 226 | O14795 | |
| SSACTNVSLLNLAAM | 76 | Q9UJT2 | |
| SAASLLQMADIAASC | 91 | Q9UFB7 | |
| AEVDCMSLLNTTLSS | 596 | O00337 | |
| NMNEASSLLSATCNT | 151 | Q9HB20 | |
| ESQQCELASTMLTAA | 831 | Q9HCJ5 | |
| QLLDLGCSLASSSMT | 126 | A2RU30 | |
| MNGLLDSDSDSLSSC | 601 | O43314 | |
| NQMGSASCELTLSVT | 221 | Q96IQ7 | |
| NMLVSDCTASSSDLG | 116 | Q9H4Z2 | |
| SCELLTSDVSQMNDR | 81 | Q5H9R7 | |
| NLHMETQTNSSIALC | 391 | Q9HD43 | |
| IDDESLPSSIQTMSC | 406 | Q9Y4A5 | |
| INCTQTSMEVSDLRS | 1371 | P15822 | |
| VSTSSLNLMAADCKQ | 236 | P29353 | |
| DCSQSLSLSTMQEDM | 1511 | Q9BVV6 | |
| SSVEDLSLSRNTMEC | 291 | Q96C45 | |
| DSFSNLLCSTEMDSL | 246 | Q96N77 |